Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

This study has been withdrawn prior to enrollment.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Edward Partridge, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00084370
First received: June 10, 2004
Last updated: August 21, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: March 2005
  Primary Completion Date: March 2005 (Final data collection date for primary outcome measure)